A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)
Clinical trial NCT00661284 · COMPLETED
Trial details
- NCT number
- NCT00661284
- Sponsor
- Chugai Pharmaceutical
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-04-01
- Primary completion
- 2009-03-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.